Impact of Hepatitis Virus on the Feasibility and Efficacy of Anticancer Agents in Patients With Hepatocellular Carcinoma in Phase I Clinical Trials

Chronic viral hepatitis is a risk factor for liver fibrosis and hepatocellular carcinoma (HCC). Patients with advanced HCC have limited effective therapeutic options and are considered potential candidates for early phase clinical trials of anti-cancer agents. The impact of chronic viral hepatitis o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Koyama, Takafumi, Kondo, Shunsuke, Shimizu, Toshio, Fujiwara, Yutaka, Morizane, Chigusa, Sakamoto, Yasunari, Okusaka, Takuji, Yamamoto, Noboru
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6482236/
https://ncbi.nlm.nih.gov/pubmed/31058094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00301
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados